ArticleClinics (Sao Paulo, Brazil)2026
Steatosis worsens ischemia-reperfusion injury post hepatectomy with intermittent inflow occlusion.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIntermittent Vascular Inflow Occlusion (VIO) is widely used during hepatectomy, but its impact on Liver Ischemia-Reperfusion Injury (LIRI) - especially in steatotic livers - remains debated. This study aims to evaluate the effects of VIO and hepatic steatosis on LIRI severity and postoperative recovery after hepatectomy.
methodsA retrospective cohort study analyzed 200 patients undergoing hepatectomy. Patients were divided into three groups according to the number of hepatic inflow occlusion episodes: N-VIO (no occlusion, n = 136), F-VIO (few-VIO, 1-2 occlusions, n = 35), and M-VIO (multiple-VIO, ≥ 3 occlusions, n = 29). After 1:1:1 Propensity Score Matching (PSM) based on surgical approach and tumor characteristics, 23 matched triplets were generated among the three groups. Liver function (ALT, AST) was assessed preoperatively and on Postoperative Days-3 (POD3) and 7 (POD7). Steatosis effects were evaluated.
resultsAt POD3, the three groups exhibited a trending overall difference in ALT levels before PSM (p = 0.009). Following PSM, no significant intergroup differences were observed at either POD3 (p = 0.422) or POD7 (p = 0.156). Collectively, these results suggest that, within the confines of the present study, variations in the number of hepatic inflow occlusions do not translate into significant differences in early postoperative ALT recovery. Steatosis significantly exacerbated IRI, with higher ALT in steatosis patients at POD3 (p = 0.026) and POD7 (p = 0.006).
conclusionsAppropriate VIO does not exacerbate LIRI. Steatosis heightens LIRI susceptibility. Patients with liver steatosis should pay more attention to controlling the number of VIO during the operation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.